Marsh & McLennan Companies (NYSE:MRSH) Stock Price Expected to Rise, Mizuho Analyst Says

Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its price objective raised by stock analysts at Mizuho from $190.00 to $200.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. Mizuho’s target price would suggest a potential upside of 6.07% from the stock’s previous close.

Several other analysts have also issued reports on MRSH. Jefferies Financial Group dropped their price objective on Marsh & McLennan Companies from $193.00 to $188.00 and set a “hold” rating on the stock in a research note on Wednesday, September 30th. Bank of America dropped their price target on Marsh & McLennan Companies from $179.00 to $178.00 and set an “underperform” rating on the stock in a research note on Wednesday, July 15th. Wells Fargo & Company lifted their price objective on shares of Marsh & McLennan Companies from $183.00 to $197.00 and gave the stock an “equal weight” rating in a research report on Friday. Morgan Stanley decreased their price objective on shares of Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 6th. Finally, UBS Group increased their price objective on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the company a “buy” rating in a research report on Tuesday, October 6th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $204.05.

View Our Latest Stock Analysis on Marsh & McLennan Companies

Marsh & McLennan Companies Stock Performance

MRSH traded up $0.20 during trading on Monday, reaching $188.55. 919,822 shares of the stock were exchanged, compared to its average volume of 2,810,063. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.09 and a current ratio of 1.09. The business’s 50 day moving average price is $181.17. Marsh & McLennan Companies has a twelve month low of $156.60 and a twelve month high of $198.49. The company has a market cap of $89.98 billion, a PE ratio of 22.53, a P/E/G ratio of 2.61 and a beta of 0.59.

Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its quarterly earnings results on Thursday, October 15th. The financial services provider reported $2.03 EPS for the quarter, beating analysts’ consensus estimates of $1.96 by $0.07. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The firm had revenue of $6.86 billion during the quarter. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Equities research analysts predict that Marsh & McLennan Companies will post 10.45 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Lloyd Yates sold 12,000 shares of the stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the transaction, the director owned 12,001 shares in the company, valued at approximately $2,107,975.65. This trade represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Paul Beswick sold 713 shares of Marsh & McLennan Companies stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the sale, the senior vice president directly owned 16,376 shares of the company’s stock, valued at approximately $3,242,448. The trade was a 4.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 19,813 shares of company stock valued at $3,597,903. 0.38% of the stock is owned by insiders.

Institutional Investors Weigh In On Marsh & McLennan Companies

A number of institutional investors have recently modified their holdings of MRSH. SHP Wealth Management acquired a new stake in Marsh & McLennan Companies in the 4th quarter worth about $26,000. Asset Dedication LLC acquired a new position in shares of Marsh & McLennan Companies during the 1st quarter worth approximately $25,000. Pinnacle Bancorp Inc. acquired a new position in shares of Marsh & McLennan Companies during the 1st quarter worth approximately $28,000. Canton Hathaway LLC bought a new position in shares of Marsh & McLennan Companies during the first quarter worth approximately $28,000. Finally, Bayban acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at approximately $34,000. Institutional investors own 87.99% of the company’s stock.

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.

Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.

Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.

See Also

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.